How one doctor’s experience inspired a new tool for Parkinson’s disease
PD in Practice
sponsored by Orbit Health
Author: Sarah McGrathPublished: 27 October 2022
Prep: Cook: Serves:
How can new technology help people with Parkinson’s manage symptoms between doctor’s appointments? This question prompted the development of Orbit Health’s Neptune and Neptune Care apps – we talk to the creators to learn more
“One major gap in Parkinson’s clinical care today is that, as a doctor, you often rely on a small snapshot of information to treat people.”
This was the challenge faced by Dr Franz MJ Pfister while working as a healthcare provider for people with Parkinson’s. To tackle the problem, Franz blended his practical experience in neurology with a Master’s in Data Science to co-found Orbit Health – a digital health company aimed at optimising care for people with the condition.
“The tools are there in terms of treatments and medications,” says Franz. “But as a doctor, I would see my patients for only about 15 minutes at a time. Because their symptoms fluctuated heavily throughout the day, this snapshot of information painted an incomplete picture – making it difficult for me to make optimal treatment decisions. What I needed was continuous insight into symptoms and Parkinson’s progression.”
This “gap” inspired Franz to begin working with sensor technology to collect motion data from people with Parkinson’s. Labelling the data minute-by-minute with support from movement disorder experts, he was eventually able to create an algorithm that tracked motor fluctuations and treatment responses experienced by people with Parkinson’s. This could, in turn, aid clinical decisions.
“Once we reached that point and had published in peer-reviewed journals, I thought about how we should go to the next level,” says Franz. “That’s when my co-founder, Patty Lee, and I had initial discussions to turn the research into a product people can use.”
Patty Lee, Orbit health co-founder and CEO.
Gaining continuous insights
The result of Franz’s research is Neptune – a wearable sensor and mobile app for healthcare providers working with people with Parkinson’s. Powered by artificial intelligence (AI), Neptune was developed for clinicians to personalise care regimens based on its motor state insights.
“You can envision it sort of like diabetes treatment, where you have a blood sugar read-out to inform the dosing and the timing of insulin intake,” says Franz. “In terms of Parkinson’s, although the treatment is there and can work quite effectively, regular adjustments are needed. Through Neptune, we are able to provide objective information to help doctors adapt treatment on a person-by-person basis.”
Now, the same technology found in Neptune can be used by people living with Parkinson’s through the launch of Neptune Care.
Orbit Health co-founder Patty Lee, who has over a decade of healthcare experience across North America, Europe and Asia, says Neptune Care is “more focused on self-management and learning”. The app enables those with the condition to log activities, such as diet, exercise, sleep, and the presence of symptoms. That information is then overlaid on a “visually intuitive” graph which highlights how various activities may affect a person’s motor symptoms, explains Patty.
“With this technology people can see how they respond to treatments throughout the day,” says Patty Lee.
For those less adept with technology, Neptune Care’s corresponding wearable sensor could still be beneficial. “As long as the person wears the sensor, the data is passively captured and processed by our AI engine to provide motor state insights,” says Patty.
She adds that a caregiver’s version of the product is currently in development, which aims to promote a more “holistic” approach to Parkinson’s management by allowing caregivers to share their own observations.
“With this technology, people with Parkinson’s can see how they respond to treatments or observe their motor states throughout the day. The more you wear the sensor and use the app, the more data and feedback Neptune Care will capture – and the more useful this tool will be,” Patty says.
“We’re looking for 100 people to take part in our Early Access Program, which will give eligible people with Parkinson’s one year of Neptune Care free of charge,” she adds, encouraging those in the community to sign up for the waiting list.
Neptune and Neptune Care are designed to help personalise care for people with Parkinson’s.
Collaboration and transformation
Franz recalls using early versions of Neptune while working at a hospital within the Schön Klinik Group in Munich, Germany: “It was amazing to see this type of objective patient information for the first time.”
Patty explains that the waitlist is open to people living with Parkinson’s worldwide. “I think it’s a very good opportunity for people to experience and be empowered by new technologies to better manage their condition,” she says. “It’s also a chance to share their voice: technology needs to continue to evolve and improve, and we want to get as much feedback as possible.”
She hopes to use this feedback to continue improving the technology: “Ultimately, we want to enable optimal care at all times for people with Parkinson’s.”
The challenge now is to “empower people to use these tools on their own” – and to ensure collaboration within the community. “Healthcare is undergoing a digital transformation for the better,” says Patty, “and we need to join hands to make it happen.”
Need to know
Patty Lee, CEO and co-founder of Orbit Health, has more than 15 years of experience in the pharmaceutical and diagnostic industries. Since leaving a global executive position with healthcare company Roche Diagnostics in Switzerland, she has consulted for tech startups in the artificial intelligence and blockchain sectors. She holds a Bachelor of Science from the University of Toronto and a Master of Business Administration (MBA) from York University of Toronto, Canada.
Dr Franz MJ Pfister, co-founder of Orbit Health, has a background that intersects between medicine, business, and data science. After completing medical studies at Ludwig Maximilian University (LMU) in Germany and Harvard Medical School, US, he earned a PhD in Neuroscience and received an MBA from Munich Business School and a Master’s in Data Science from LMU. He is based in Munich, Germany.
This article was sponsored by Orbit Health. For more details about Neptune and Neptune Care, visit the company’s website. If you have any questions, please contact Orbit Health via email at email@example.com or WhatsApp at (+49)15209474820.
Busting Parkinson’s disease myths with our new infographic
A resource to share this World Parkinson’s Day
7 days ago
Investigational Parkinson’s disease dementia therapy fails in clinical trial
Research into new potential therapies for people with Parkinson’s is complex, which means that not all clinical trials will successfully move on to the next phase. This proved to be the case for US biotech company Aptinyx, which announced that it will halt further development work on an investigational therapy following “disappointing” results in the second phase of its study. The research had set out to examine the effect of NYX-458 – an oral therapy created to modulate the activity of receptors in the brain that are responsible for communication between neurons. The aim of the therapy was to improve cognition in people with cognitive impairment linked to Parkinson’s or Lewy body dementia. Yet, when compared to a placebo, the therapy didn’t demonstrate “meaningful improvements” in cognitive function. Dr Andy Kidd, president and CEO at Aptinyx, said: “We are very disappointed that the results of this Phase 2 study did…
A new intimacy guide aims to support people with Parkinson’s disease in the US
Does sexual wellness in the Parkinson’s community need more focus? It’s an area that the American Parkinson Disease Association (APDA) and media brand Havas Health Plus have targeted through the launch of a free intimacy guide. Available to people in the US, ‘The ParkinSex Booklet & Kit’ aims to support those whose relationships may have been impacted by emotional and physical distance linked to the condition. Alongside an educational guide, the kit includes items such as candles, coupons for adaptative clothing and massage stones. Following a positive response to an initial pilot distribution of the guides in the US, there is now a waitlist for future kits. Commenting on the launch in a press release, APDA president and CEO Leslie Chambers said: “The challenges of Parkinson’s can often result in intimacy and connection getting left behind. This is why we created ‘The ParkinSex Booklet & Kit’, to help people with…
How prevalent are non-visual hallucinations in Parkinson’s disease?
Some people in the later stages of Parkinson’s can experience hallucinations – “when you see, hear or feel things that aren’t there”. With most research into this topic centred on visual hallucinations, a team in Australia set out to investigate data around non-visual hallucinations in people with the condition. Published in the ‘Journal of Neurology’, the analysis drew on 91 relevant studies released between 1970 and 2022. The team found that visual hallucinations appeared to be most common, with an expected prevalence of up to 96.6%. Meanwhile, non-visual hallucinations – including auditory (relating to the sense of hearing) and olfactory (relating to the sense of smell) – had an estimated prevalence of up to 73.3%. Concluding that non-visual hallucinations may “impact a notable proportion” of people with the condition, the team said: “More direct research and clinical attention need to be devoted to the study and management of such hallucinatory…